The Infectious Diseases Society of America and its HIV Medicine Association strongly support the incoming Administration’s request for $400 billion to strengthen our pandemic response and safely reopen schools.
Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.
The HIV Medicine Association is pleased to announce the special appointment of Marwan Haddad, MD, MPH, as chair-elect. Dr. Haddad served on the HIVMA Board of Directors from October 2017 to October 2020 and is medical director of the Center for Key Populations for Community Health Center, Inc.
The current obstacles to swift and widespread COVID-19 vaccine access are impeding control of the pandemic amid soaring rates of infections, illnesses, hospitalizations and deaths and must be addressed effectively and immediately.
The bipartisan bill passed by the House and the Senate and signed by the president provides urgently needed resources to confront COVID-19, funds critical programs across the government in 2021 and offers great hope for recovery from some of the pandemic’s damaging impacts in the year to come.
The emergency use authorization of a second COVID-19 vaccine today means that millions more people can be immunized against this virus in the weeks to come.
AABB and the Infectious Diseases Society of America issued today a resource document outlining considerations for clinicians on the use of COVID-19 convalescent plasma under the Emergency Use Authorization granted by the Food and Drug Administration.
“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement
Congressional Rep. Mike Doyle (D-PA) and Rep. Drew Ferguson (R-GA) today introduced The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
In a Dec. 7 letter to National Institutes of Health Director Francis Collins, MD, PhD, on the agency’s Strategic Plan for COVID-19 Research, IDSA President Barbara Alexander, MD, MHS, FIDSA, calls for cross-cutting strategies
The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.
In the face of new challenges to the access to testing, prevention, care and treatment necessary to stop HIV transmissions, infections, illnesses and deaths at home and globally, the theme of this year’s World AIDS Day: Ending the HIV/AIDS Epidemic: Resilience and Impact must drive the efforts ahead.